How Big Picture of interferon-induced antiviral defense genes Launch Revealed

Schoggins and his colleagues hope their work will ultimately help inform the design of new antiviral drugs. Continue reading →

Pot Slows Cancer in vitro

Cannabinoids could keep dangerous tumors spread throughout the body? Ramer and Hinz set up an experiment in which invasive cervical cells and make their way through a gel-like tissue. Even at very low concentrations, the marijuana compounds THC and methanandamide (MA) has significantly slowed the invading cancer cells. Continue reading →

Improving health care decisions through the research to practice

The report is a comprehensive analysis conducted by 90 international experts. The European Medical Research Councils (EMRC) is the membership organization for all medical research councils in Europe, representing the communities of medical research in 30 countries. Are forward-looking strategic foresight activities for the European scientific community and policy makers to define research agendas at national and European level. Continue reading →

Important control mechanism behind autoimmune diseases discovered

Researchers at the Medical University Karolinska Institutet in Sweden have discovered a new mechanism to control our immune system. The discovery is of potential importance for the treatment of serious diseases such as MS () and LES (erythematous). Continue reading →

Fiery Pepper Fatal for fat cells?

First, an extract of capsaicin prepared in their laboratory. Then they marinated preadipocytes mouse capsaicin extract for eight days, update the capsaicin extract every other day. Continue reading →

3 Tesla MRI offers unique information to the clinic

‘With the addition of this high-end system, Nuada located in Queen Anne Street Medical will be able to offer patients a better quality of service diagnostics with the comfort of large diameter for patients,’ said Gary Cook, Regional Sales Manager at Siemens Healthcare. ‘A team full of experts in the management of health care will help make the best use of innovative technologies on the site. The ease of use and system footprint allows significant benefits to the 3 Tesla imaging be appreciated by clinical and research fellows ‘. Continue reading →

Spanish Health Survey Finds Women live longer but in worse shape

It ‘too early to demonstrate the impact of the 2006 law, said Espelt. The Public Health Agency of Barcelona is already planning a new health survey for 2011, which will include the same questions as the previous one. Continue reading →

Women business less likely to report pain than their male counterparts

The study found that women veterans were less likely to report any type of pain (38.1percent vs. Veterans without pain, the researchers found women veterans were more likely to report moderate to severe pain (68.0percent vs. 62.6percent) and less likely to report having persistent pain (18.0percent vs. 21, 2 percent) than their male colleagues. ‘We were surprised by the low prevalence of pain in women veterans is contrary to studies in civilian populations,’ said Dr. Haskell. Continue reading →

NanoLogix Announces European clinical trial of its rapid detection kits

NanoLogix (Pink Sheets: NNLX), a biotechnology innovation in the rapid detection and identification of live cells of bacteria and microorganisms, announced today its BioNanoFilter (BNF) technology will be the subject of a clinical trial, led by Dr. Gian Carlo Di Renzo, University of Perugia in Italy. The trial will study 300 patients, the speed and accuracy NanoLogix technology beyond the current methods for detection and identification of group B streptococci (GBS) in pregnant women. This is 8 to 24 times faster than traditional methods. The process will be the second trial of the technology NanoLogix BNF for group A streptococcal BI results of this study will help to speed up the approval of the kit BNF for use in Europe, North Africa and Middle East. Continue reading →

Scientists at The Scripps Research Identify key interactions in hepatitis C

Hepatitis C affects between 130 and 170 million people worldwide and is the cause of an epidemic of liver. Because current treatments for HCV are only partially effective, a number of other molecular mechanisms that are being actively pursued as a possible target of the drug. Continue reading →